Tobin M Abraham1, Alison Pedley1, Joseph M Massaro1, Udo Hoffmann1, Caroline S Fox2. 1. From National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (T.M.A., C.S.F.); National Heart, Lung, and Blood Institute, Bethesda, MD (T.M.A., C.S.F.); Department of Endocrinology, Hypertension, and Diabetes, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (T.M.A., A.P., C.S.F.); Department of Biostatistics, Boston University School of Public Health, MA (J.M.M.); and Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston (U.H.). 2. From National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (T.M.A., C.S.F.); National Heart, Lung, and Blood Institute, Bethesda, MD (T.M.A., C.S.F.); Department of Endocrinology, Hypertension, and Diabetes, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (T.M.A., A.P., C.S.F.); Department of Biostatistics, Boston University School of Public Health, MA (J.M.M.); and Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston (U.H.). foxca@nhlbi.nih.gov.
Abstract
BACKGROUND: Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) vary in volume and quality. We evaluated whether fat volume or attenuation (indirect measure of quality) predicts metabolic risk factor changes. METHODS AND RESULTS: Framingham Heart Study Multi-detector Computed Tomography Substudy participants (n=1730, 45% women) were followed up over a mean of 6.2 years. Baseline VAT and SAT volume (in cm(3)) and attenuation (in Hounsfield units) were assessed. Outcomes included blood pressure, lipids, and glucose. We constructed multivariable regression models predicting change from baseline to follow-up. Baseline VAT was associated with metabolic risk factors at follow-up. Per 500-cm(3) increase in baseline VAT, glucose was 2.34 mg/dL higher (95% confidence interval, 1.71-2.97) and high-density lipoprotein was 1.62 mg/dL lower (95% confidence interval, 0.97-2.28) in women (P<0.0001 for both). These findings remained significant after adjustment for body mass index. Results for SAT were similar although less striking. Lower (more negative) fat attenuation was associated with more adverse metabolic profiles at follow-up. For example, per 5-unit decrease in baseline VAT Hounsfield units, log triglycerides increased by 0.08 mg/dL (95% confidence interval, 0.05-0.12; P=0.005), which remained significant after adjustment for baseline VAT. Among men, VAT and SAT Hounsfield units were associated with changes in cardiovascular disease risk factors but were mostly attenuated after baseline volume adjustment. CONCLUSIONS: VAT volume and SAT volume are associated with incident metabolic risk factors beyond overall adiposity. Decreases in fat attenuation are also associated with incident risk factors. These findings suggest that both volume and quality of VAT and SAT contribute to metabolic risk.
BACKGROUND: Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) vary in volume and quality. We evaluated whether fat volume or attenuation (indirect measure of quality) predicts metabolic risk factor changes. METHODS AND RESULTS: Framingham Heart Study Multi-detector Computed Tomography Substudy participants (n=1730, 45% women) were followed up over a mean of 6.2 years. Baseline VAT and SAT volume (in cm(3)) and attenuation (in Hounsfield units) were assessed. Outcomes included blood pressure, lipids, and glucose. We constructed multivariable regression models predicting change from baseline to follow-up. Baseline VAT was associated with metabolic risk factors at follow-up. Per 500-cm(3) increase in baseline VAT, glucose was 2.34 mg/dL higher (95% confidence interval, 1.71-2.97) and high-density lipoprotein was 1.62 mg/dL lower (95% confidence interval, 0.97-2.28) in women (P<0.0001 for both). These findings remained significant after adjustment for body mass index. Results for SAT were similar although less striking. Lower (more negative) fat attenuation was associated with more adverse metabolic profiles at follow-up. For example, per 5-unit decrease in baseline VAT Hounsfield units, log triglycerides increased by 0.08 mg/dL (95% confidence interval, 0.05-0.12; P=0.005), which remained significant after adjustment for baseline VAT. Among men, VAT and SAT Hounsfield units were associated with changes in cardiovascular disease risk factors but were mostly attenuated after baseline volume adjustment. CONCLUSIONS: VAT volume and SAT volume are associated with incident metabolic risk factors beyond overall adiposity. Decreases in fat attenuation are also associated with incident risk factors. These findings suggest that both volume and quality of VAT and SAT contribute to metabolic risk.
Authors: Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy Journal: Am J Epidemiol Date: 2007-03-19 Impact factor: 4.897
Authors: P Maurovich-Horvat; J Massaro; C S Fox; F Moselewski; C J O'Donnell; U Hoffmann Journal: Int J Obes (Lond) Date: 2006-09-05 Impact factor: 5.095
Authors: Caroline S Fox; Joseph M Massaro; Udo Hoffmann; Karla M Pou; Pal Maurovich-Horvat; Chun-Yu Liu; Ramachandran S Vasan; Joanne M Murabito; James B Meigs; L Adrienne Cupples; Ralph B D'Agostino; Christopher J O'Donnell Journal: Circulation Date: 2007-06-18 Impact factor: 29.690
Authors: Karla M Pou; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; Pal Maurovich-Horvat; Martin G Larson; John F Keaney; James B Meigs; Izabella Lipinska; Sekar Kathiresan; Joanne M Murabito; Christopher J O'Donnell; Emelia J Benjamin; Caroline S Fox Journal: Circulation Date: 2007-08-20 Impact factor: 29.690
Authors: Elizabeth M Cespedes Feliciano; Wendy Y Chen; Patrick T Bradshaw; Carla M Prado; Stacey Alexeeff; Kathleen B Albers; Adrienne L Castillo; Bette J Caan Journal: J Clin Oncol Date: 2019-08-01 Impact factor: 44.544
Authors: Curtis Tilves; Joseph M Zmuda; Allison L Kuipers; J Jeffrey Carr; James G Terry; Victor Wheeler; Shyamal D Peddada; Sangeeta Nair; Iva Miljkovic Journal: Obesity (Silver Spring) Date: 2019-12-24 Impact factor: 5.002
Authors: Luisa Ciuffo; Hieu Nguyen; Mateus Diniz Marques; Konstantinos N Aronis; Bhradeev Sivasambu; Henrique D de Vasconcelos; Susumu Tao; David D Spragg; Joseph E Marine; Ronald D Berger; Joao A C Lima; Hugh Calkins; Hiroshi Ashikaga Journal: Circ Cardiovasc Imaging Date: 2019-06-10 Impact factor: 7.792
Authors: Anne Gangloff; Jean Bergeron; Isabelle Lemieux; Angelo Tremblay; Paul Poirier; Natalie Alméras; Jean-Pierre Després Journal: Int J Obes (Lond) Date: 2019-03-29 Impact factor: 5.095
Authors: Tae Hee Lee; Pratyusha Tirumani Setty; Gopanandan Parthasarathy; Kent R Bailey; Christina M Wood-Wentz; Joel G Fletcher; Naoki Takahashi; Sundeep Khosla; Michael R Moynagh; Alan R Zinsmeister; Adil E Bharucha Journal: Mayo Clin Proc Date: 2018-09 Impact factor: 7.616
Authors: Perry J Pickhardt; Peter M Graffy; Ryan Zea; Scott J Lee; Jiamin Liu; Veit Sandfort; Ronald M Summers Journal: Lancet Digit Health Date: 2020-03-02